A clinical decision tool for rapid assessment of cardiac chest pain.
- Conditions
- Acute coronary syndromeCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12611000206921
- Lead Sponsor
- Investigator initiated study - Dr Louise Cullen, Senior Staff Specialist
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1000
Patient with symptoms of greater than or equal to 5 minutes consistent with possible ACS (chest discomfort or angina equivalent)
AND/OR
Physician plans to evaluate the patient for potential ACS
AND
Intermediate risk features on QLD CPP
More than 2 hours since arrival at hopsital.
Patient (or Legal Representative) is unable or unwilling to provide informed consent.
Transfer from other hosptial.
Patient (or Legal Representative) refusal of telephone follow-up or medical record review at 30 days or unlikely to be contactable for follow-up.
Reasearcher does not feel that informed consent is obtainable or that recruitment is apporpriate (e.g. terminal illness).
Pregnant.
Clear alternative non-ACS diagnostic cause for symptoms.
High risk features according to QLD CPP.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnosis of ACS-related events, using the AHA/ACC/ESC/WHO task force universal definition of myocardial infarction. <br>The primary endpoint is adjudicated by cardiologists using all available investigations, telephone follow up calls and clinical notes for 30 day events.[30 days]
- Secondary Outcome Measures
Name Time Method The secondary outcome will include a composite outcome of those admitted to hospital for potential ACS. That is, those diagnosed with AMI or ACS on admission or those who have a significant EST finding. This endpoint is adjudicated by cardiologists using all available investigations, telephone follow up calls and clinical notes for 30 day events.[30 days]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.